Diamond Biofund Inc. is a venture capital firm specializing in evergreen funds. The firm seeks investment in start-ups and early ventures. It typically invests in biotechnology and medical investments, including new drug R&D, high-end medical equipment, innovative medical services and channels, and agricultural biotechnology. Diamond Biofund Inc. was founded in 2013 and is based in Taipei, Taiwan.
Frequently asked questions
What sector does DIAMOND BIOFUND INC (6901) operate in?
DIAMOND BIOFUND INC belongs to the Financials sector and operates in the Asset Management industry.
What is DIAMOND BIOFUND INC (6901) current stock price?
As of the latest data, DIAMOND BIOFUND INC stock price is NT$17.35, with a previous close of NT$17.35.
What is DIAMOND BIOFUND INC (6901) current market capitalization?
DIAMOND BIOFUND INC market cap is approximately 14.80 billion.
What is DIAMOND BIOFUND INC (6901) Earnings Per Share (EPS)?
The trailing EPS is -NT$1.13.
What is DIAMOND BIOFUND INC (6901) EBITDA?
DIAMOND BIOFUND INC EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -348.63 million.
Does DIAMOND BIOFUND INC (6901) pay dividends?
No. DIAMOND BIOFUND INC does not pay a dividend.
What is DIAMOND BIOFUND INC (6901) beta (volatility) score?
DIAMOND BIOFUND INC has a beta of 0.949, meaning its volatility is roughly in line with the market.